Sort
50,496 grants matching “lung cancer”
Chemical Tools for Studying Fucosylated Glycans
$470,643Peng Wu · Scripps Research Institute, The · R01 · FY2016 · GM
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
$470,637Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2018 · CA
The Oncogenic and Tumor Suppressor Functions of the Kras isoform 4A in vivo
$470,631Allan Balmain · University Of California, San Francisco · R01 · FY2016 · CA
UCLA Clinical Scientist Training in Cancer Gene Medicine
$470,621University Of California Los Angeles · K12 · FY2003 · CA
Functions of the LKB1 tumor suppressor in control in metabolism and epigenetics
$470,621Nabeel Bardeesy · Massachusetts General Hospital · R01 · FY2022 · CA
Healthcare Access Dimensions and Racial Disparities in Lung Cancer
$470,547Ying Liu · Washington University · R01 · FY2024 · MD
Tumor microenvironment: Impact on T cell tumor-targeting, activation and survival
$470,514Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Rac guanine nucleotide exchange factors in lung cancer
$470,493Marcelo Gabriel Kazanietz · University Of Pennsylvania · R01 · FY2022 · CA
Transcriptional regulation of breast cancer metastasis
$470,456Zena Werb · University Of California, San Francisco · R01 · FY2009 · CA
R01- Mapping environmental contributions to rapid lung disease progression in cystic fibrosis
$470,453Rhonda Szczesniak · Cincinnati Childrens Hosp Med Ctr · R01 · FY2021 · HL
Cancer Genetic Markers of Susceptibility
$470,422Stephen J Chanock · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
Computational Model of Autophagy-Mediated Survival in Chemoresistant Lung Cancer
$470,406Jeffrey Paul Mackeigan · Michigan State University · R01 · FY2018 · CA
Protein Kinase C Signaling Mechanisms in Cancer
$470,306Alan P Fields · Mayo Clinic Jacksonville · R01 · FY2019 · CA
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
$470,246Ruoning Wang · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · CA
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
$470,246Ruoning Wang · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · CA
Utilizing Interaction to Identify Novel Genetic Factors for Nicotine Dependence
$470,202Dana B Hancock · Research Triangle Institute · R01 · FY2015 · DA
Whole Mouse Cryo-Imaging
$470,128David L Wilson · Bioinvision, Inc. · R42 · FY2009 · CA
Development of Medical Countermeasures to Ricin Poisoning
$470,101Thor Jon Borgford · Twinstrand Therapeutics, Inc. · U01 · FY2008 · AI
Accelerated statistical image reconstruction methods for X-ray CT
$470,100Jeffrey A Fessler · University Of Michigan At Ann Arbor · U01 · FY2015 · EB
Chronic Respiratory Effect and Control of Occupational Exposure of Wildland Firefighters to Smoke
$470,054Olorunfemi Adetona · Ohio State University · R01 · FY2023 · OH
Tumor-targeted nanoparticle-based delivery system for imaging and treatment of cancer
$470,010Tamara Minko · Rutgers, The State Univ Of N.J. · R01 · FY2017 · CA
Phase I/II clinical evaluation of ABTL0812, a novel PI3K/Akt/mTOR inhibitor, with a unique mechanism of action inpancreatic cancer (Protocol sent on 20th June 2019 as an amendment of the IND 137394)
$470,000Davendra Sohal · University Of Cincinnati · R01 · FY2020 · FD
Immunoglobulin-Driven Activation of the Complement Cascade is a Critical Determinant of PAH Initiation and Progression
$469,957Kurt R Stenmark · University Of Colorado Denver · P01 · FY2021 · HL
Immunoglobulin-Driven Activation of the Complement Cascade is a Critical Determinant of PAH Initiation and Progression
$469,957Kurt R Stenmark · University Of Colorado Denver · P01 · FY2023 · HL
Immunoglobulin-Driven Activation of the Complement Cascade is a Critical Determinant of PAH Initiation and Progression
$469,957Kurt R Stenmark · University Of Colorado Denver · P01 · FY2022 · HL